Visual Function in CaV1.4-Deficient Mice  by Shaltiel, Lior et al.
Sunday, February 26, 2012 127aat 24 C but only 205 3.0% at 37 C; time to peak increased from 2.45 0.4 to
34.55 2.4 ms (control vs TTYC) at room temperature and from 5.65 0.4 to
1305 14 ms at 37 C. TTYC produced similar V1/2 shifting (to the left) in the
activation curves at room (10.2 vs. 2.2 mV) and physiology (23.5 vs.
14.2 mV) temperatures. In summary, these results confirm that temperature
is an important modulator of the L-type calcium channels expressed in CHO
cells, and further demonstrate that the natural modulator (temperature) of
L-type calcium channel influences its pharmacological responses to a channel
activator in terms of peak current amplitude and biophysical properties.
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CACNA1F encodes the alpha1 subunit of retina-specificCav1.4 voltage-gated L
type calcium channels. Mutations in this gene cause congenital stationary night
blindness type 2A (CSNB2), Aland Island eye disease (AIED) and cone-rod dys-
trophy type 3 (CORDX3). The clinical phenotypes of these eye diseases vary
substantially regarding the ratio of rod to cone functional impairment. The rea-
sons for this variability are not known. To gainmore insights into the pathophys-
iology caused by loss of Cav1.4 function we analyzed the visual phenotype of
Cav1.4-deficient mice. To this end, we combined immunohistochemistry, elec-
troretinography (ERG) and vision-dependent behavioral testing. Immunohisto-
chemical analysis using synaptic and postsynaptic markers revealed severe
synaptic defects in Cav1.4-deficient mice. Heterozygous Cav1.4 mice showed
mosaic synaptic defects most probably caused by random X-chromosomal
inactivation of the healthy allele. Electroretinography revealed a loss of scotopic
and photopic photoreceptor function. This loss of retinal network function
resulted in impaired perfomance of Cav1.4 knockout mice in a water maze-
based behavioral test of rod and cone function. In conclusion, loss of Cav1.4
channels strongly impairs rod and cone retinal function and vision in mice.
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Multiple mutations in human CACNA1A, the gene encoding the pore-forming
CaV2.1 subunit of P/Q-type VGCCs, have been associated with many neuro-
logical diseases including familial hemiplegic migraine type 1 (FHM-1), ep-
isodic ataxia type 2 (EA2) and epilepsy. The effects of many CACNA1A
mutations on the biophysical properties of the P/Q-type channels have been
extensively studied. However, questions remain as to whether and how these
mutations affect CaV2.1 protein expression and/or the plasma membrane traf-
ficking. To develop tools in exploring the mechanisms underlying CaV2.1 traf-
ficking, we inserted a 15 amino acids epitope (PQ-I) in the IS5-S6 loop of
human CaV2.1 into the hepatitis B virus core (HBc) protein. The virus-like
particles self-assembled from the HBc-PQ-I fusion protein was used to immu-
nize mice to obtain antisera. The PQ-I antibody specifically recognized human
CaV2.1 subunits expressed in HEK293 cells but not CaV1.2, CaV2.2 or
CaV2.3. Next, we expressed EGFP-tagged wild-type or mutant CaV2.1 sub-
units in HEK cells and examined CaV2.1-immunoreactivity (CaV2.1-ir) in
transfected, non-permeabilized cells with PQ-I antibody. EGFP signals were
observed in both the plasma membrane and intracellular compartments. In
contrast, CaV2.1-ir was restricted to the cell surface. Our data showed that
missense FHM-1 mutations did not affect the expression or the plasma mem-
brane trafficking of CaV2.1 subunits. On the contrary, the nonsense EA2 mu-
tation Y1854X resulted in a significant reduction of both CaV2.1 protein
expression as well as its efficiency of trafficking to the plasma membrane.
This may account for the diminished current through Y1854X mutant chan-
nels. Furthermore, the PQ-I antibody did not attenuate P/Q-type currents,
nor did it affect the effect of P/Q-channel blocker-agatoxin-IVA, suggestingthat it can be used to track CaV2.1 trafficking in vivo without perturbing its
physiological functions.639-Pos Board B425
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Caveolin-3 (Cav-3) is a critical scaffolding protein essential for caveolae for-
mation. In cardiomyocytes, caveolae serve as important Ca2þ microdomains
where several ion channels localize including voltage-gated Naþ and L-type
Ca2þ channels (LTTCs). Our previous studies have shown that Long QT Syn-
drome (LQTS)-associated Cav-3 F97C and S141R mutations increased sodium
channel late current, but it is unknown if these mutations impact LTTCs. We
co-expressed Cav-3 WT, F97C, or S141R with Cav1.2 þ Cavb2cN4 in HEK
293 cells and measured LTCC currents (ICa,L) using whole-cell perforated
patch clamp with 10 mM Ca2þ or 10 mM Ba2þ as the charge carrier. Cav-3
S141R transfected cells showed increased ICa,L peak current density
(13.9551.86 pA/pF, p<0.05) compared to F97C (7.5951.99 pA/pF) and
WT (9.4752.38 pA/pF). Analysis of ICa,L inactivation shows that Cav-3
F97C (r100: 0.3550.03) slows inactivation compared to S141R and WT
(0.2450.04 and 0.1350.03, respectively; p<0.05). However, there were no
significant differences in IBa,L current density or inactivation observed between
Cav-3 WT, F97C, and S141R. Experiments were also performed in mouse neo-
natal ventricular myocytes transfected with Cav-3 WT, F97C, or S141R. Cav-3
S141R (6.9850.97 pA/pF) increased peak ICa,L current density compared to
F97C and WT (2.6250.87 and 3.7650.72 pA/pF, respectively; p<0.05).
Analysis of ICa,L inactivation showed that both Cav-F97C and S141R (r75:
0.1350.02 and 0.1350.02, respectively, p<0.05) slowed inactivation com-
pared to WT (0.0550.02). LQT Cav-3 F97C and S141R mutations alter
calcium-dependent LTTC function by reducing Ca-dependent inactivation
and for S141R increasing current density. In conclusion, these results suggest
a newly identified role in which Cav-3 is part of the complex which regulates
calcium-dependent inactivation of cardiac LTTCs. Furthermore, the LQT
Cav-3 mutations, F97C and S141R, show important gain-of-function effects
which will prolong repolarization and contribute to arrhythmogenesis.
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Although the effect of aldosterone beyond the epithelia is now well recognized,
specific action through the mineralocorticoid receptor (MR) in heart is still mat-
ter of debate. In the past decade, we have accumulated evidence, both ex vivo
and in vivo, that modulation of Ca2þ signaling, especially Ca2þ influx via L-
type Ca2þ channel (Cav1.2), is a central factor in the cardiac action of aldoste-
rone. Even if our results established that a specific transcriptional upregulation
is involved in the effect of aldosterone on Cav1.2, it cannot be concluded
whether this genomic effect is direct or indirect. The effect of the mineralocor-
ticoid, aldosterone, on the regulation of the cardiac Cav1.2 expression was in-
vestigated in primary cultures of neonatal rat ventricular myocytes (nRVM). By
use of quantitative real time RT-PCR, we found that aldosterone increased the
Cav1.2 mRNA amount in time- and dose-dependent manner. This up-
regulation appeared as early as 1hour of incubation even with 1 nM aldoste-
rone. Inspection of the upstream promoter region from rat Cav1.2 encoding
gene, revealed one putative hormone response element, GRE. The activity of
the promoter-luciferase reporter gene constructs in transfected nRVMs showed
similar time- and dose-dependent stimulation with aldosterone. We will exam-
ine the intracellular trafficking of MR in nRVMs using a fusion protein of green
fluorescent protein and human MR. Selectivity of these effects will be tested as
well as electrophoretic mobility shift assays to identify the region of the cac-
na1c promoter that can bindMRs. The data will provide new insights in the mo-
lecular mechanisms underlying the regulation of Cav1.2 channel expression by
mineralocorticoids.
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In neurons, L-type voltage-gated Ca2þ channels (L-channels) provide Ca2þ sig-
nals that help control gene expression. Consequently, regulation of L-channel
